# CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection

> **NCT06994975** · PHASE3 · RECRUITING · sponsor: **Huashan Hospital** · enrollment: 890 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** 0.25mg/kg TNK
- **DRUG:** Standard medical treatment

## Key facts

- **NCT ID:** NCT06994975
- **Lead sponsor:** Huashan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-03
- **Primary completion:** 2028-03
- **Final completion:** 2028-06
- **Target enrollment:** 890 (ESTIMATED)
- **Last updated:** 2025-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06994975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06994975, "CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06994975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*